Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: waldosworld & patriotism / Re: Shareholder Letter
10
Jan 15, 2008 12:18PM

Jan 15, 2008 12:21PM

Jan 15, 2008 12:53PM

Jan 15, 2008 12:58PM
Actually, PDS licensing revenues for the last quarter were $19.433M.  Revenues for the last SIX months were $20.933M.
Share
New Message
Please login to post a reply